Potassium channel blocker dofetilide does not abolish ischaemic preconditioning

References

• Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124–36
   PubMed Web of Science ®Google Scholar
• Thornton JD, Liu GS, Downey JM. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol 1993; 25: 311–20
   PubMed Web of Science ®Google Scholar
• Van Winkle DM, Chien GL, Wolff RA, Soifer BE, Kuzume K, Davis RF. Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol 1994; 266: H829–H839
   Google Scholar
• Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266: H1145–H52
   PubMedGoogle Scholar
• Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994; 26: 661–8
   PubMed Web of Science ®Google Scholar
• Auchampach JA, Grover GJ, Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 1992; 26: 1054–62
   PubMed Web of Science ®Google Scholar
• Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993; 27: 617–22
   PubMed Web of Science ®Google Scholar
• Rasmussen HS, Allen MJ, Blackburn KJ, Butrous GS, Dalrymple HW. Dofetilide, a novel class III antiarrhythmic agent. J Cardiovasc Pharmacol 1992; 20(Suppl 2)S96–105
   Google Scholar
• Tande PM, Bjornstad H, Yang T, Refsum H. Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug. UK-68,798: potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol 1990; 16: 401–10
   PubMed Web of Science ®Google Scholar
• Tohse N, Kameyama M, Sekiguchi K, Shearman MS, Kanno M. Protein kinase C activation enhances the delayed rectifier potassium current in guinea-pig heart cells. J Mol Cell Cardiol 1990; 22: 725–34
   PubMed Web of Science ®Google Scholar
• Habuchi Y, Tanaka H, Furukawa T, Tsujimura Y, Takahashi H, Yoshimura M. Endothelin enhances delayed potassium current via phospholi-pase C in guinea pig ventricular myocytes. Am J Physiol 1992; 262: H345–H354
   Google Scholar
• Yang T, Tande PM, Lathrop DA, Refsum H. Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia-induced electromechanical changes. Cardiovasc Res 1992; 26: 1109–15
   PubMed Web of Science ®Google Scholar
• Grover GJ, D'Alonzo AJ, Parham CS, Darbenzio RB. Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol 1995; 26: 145–52
   PubMed Web of Science ®Google Scholar
• Kanaan N, Jenkins J, Kadish A. PACE Pacing. Clin Electrophysiol 1990; 13: 196–206
   PubMedGoogle Scholar
• Mortensen E, Yang T, Refsum H. Class III antiarrhythmic action and inotropy: effects of dofetilide in acute ischemic heart failure in dogs. J Cardiovasc Pharmacol 1992; 19: 216–21
   PubMed Web of Science ®Google Scholar
• Gwilt M, Blackburn KJ, Burges RA, Higgins AJ, Milne AA, Solca AM. Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs. Eur J Pharmacol 1992; 215: 137–44
   PubMed Web of Science ®Google Scholar
• Tweedie D, Henderson C, Kane K. Glibenclamide, but not class III drugs, prevent ischaemic shortening of the refractory period in guinea-pig hearts. Eur J Pharmacol 1993; 240: 251–7
   PubMed Web of Science ®Google Scholar
• Reed LJ, Alabaster CT, Barclay PL. Comparative effects of dofetilide and d-sotalol in guinea-pig Langendorff hearts during simulated ischae-mia ‘abstract’. J Mol Cell Cardiol 1994; 26: CCLIV
   Google Scholar
• Bril A, Faivre JF, Landais L, Gout B. Defibrillatory action of dofetilide and glibenclamide on reperfusion arrhytmias in the rat: blockade of the ATP-sensitive potassium channel as common mechanism ‘abstract’. J Mol Cell Cardiol 1992; 24(Suppl V)68
   Google Scholar
• Gibbs CL, Johnson EA. Effect of changes in frequency of stimulation upon rabbit ventricular action potential. Circ Res 1961; 9: 165–70
   PubMed Web of Science ®Google Scholar
• Edwards G, Weston AH. KATP—fact or artefact? New thoughts on the mode of action of the potassium channel openers. Cardiovasc Res 1994; 28: 735–7
   PubMed Web of Science ®Google Scholar
• Ashcroft FM, Coles B, Kenna S, Proks P, Roper J, Reid J, et al. The KATP and Kv channels are distinct entities: a reply to Edwards and Weston ‘comment’. Cardiovasc Res 1994; 28: 738–740
   PubMed Web of Science ®Google Scholar
• Carmeliet E. KATP channels fact or artefact?. Cardiovasc Res 1994; 28: 925–8
   Google Scholar
• Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 1993; 72: 44–9
   PubMed Web of Science ®Google Scholar
• Walsh RS, Tsuchida A, Daly JJ, Thornton JD, Cohen MV, Downey JM. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc Res 1994; 28: 1337–41
   PubMed Web of Science ®Google Scholar
• Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70: 223–33
   PubMed Web of Science ®Google Scholar
• Rohmann S, Weygandt H, Schelling P, Soei LK, Verdouw PD, Lues I. Involvement of ATP-sensitive potassium channels in preconditioning protection. Basic Res Cardiol 1994; 89: 563–76
   PubMed Web of Science ®Google Scholar